Neoskin

Neoskin Biotecnologia is a Brazilian biotechnology company specializing in tissue engineering and regenerative medicine for dermatology and wound care. The company develops advanced bioengineered skin substitutes designed to treat severe burns and chronic wounds, such as diabetic foot ulcers and pressure sores. Their core technology involves the cultivation of human skin cells (keratinocytes and fibroblasts) on specialized biological scaffolds to create functional, living tissue replacements that mimic the structure of human skin. Neoskin aims to provide a more effective alternative to traditional skin grafts, focusing on accelerating healing rates and reducing patient morbidity in complex dermatological cases. The company operates primarily within the Latin American market, leveraging partnerships with regional technology institutes and government innovation agencies.